InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Keutzer Timothy, Directeur du Développement. Director active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 10 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €45k. Activity tracked since 26 August 2021. The latest transaction was disclosed on 6 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Keutzer Timothy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
18,652 shares@ US$2.3682.9% of flowCommon StockSEC:0001193125-26-043315:0
68,000 shares0Common StockSEC:0001193125-26-038441:0
1,695 shares@ US$1.9737.2% of flowCommon StockSEC:0000950170-25-112659:0
266,139 shares0Common StockSEC:0000950170-25-014866:0
2,213 shares@ US$1.3555.3% of flowCommon StockSEC:0000950170-24-101998:0
239,731 shares0Common StockSEC:0000950170-24-011501:0
1,854 shares@ US$1.2644.7% of flowCommon StockSEC:0000950170-23-045450:0
265,957 shares0Common StockSEC:0000899243-23-003948:0
38,014 shares0Common StockSEC:0000899243-22-004589:0
24,067 shares0Common StockSEC:0000899243-21-034499:0
10 of 10 declarations
About Keutzer Timothy
Keutzer Timothy is Directeur du Développement and Chief Operating Officer at Spero Therapeutics, Inc. The 10 filings on record, covering the sampled recent filings from 2021-08-30 to 2026-02-09, show 0 € in purchases and 45063 € in sales, with the stated transaction nature being Attribution.
